Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.294, 2001-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Postcode prescribing of antidementia drugs persists in the UK
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 445, 2004-01 ,pp. :
Diabetes care still a postcode lottery in the UK
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 618, 2010-01 ,pp. :
IFN- -2b + ribavirin preferred initial treatment for hep C
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 274, 2000-01 ,pp. :
IFN- -2b + ribavirin preferred initial treatment for hep C
Inpharma, Vol. 1, Iss. 1249, 2000-01 ,pp. :
Peginterferon-α-2b + ribavirin for hep C during methadone treatment
Inpharma, Vol. 1, Iss. 1575, 2007-01 ,pp. :